MedPath

GADOPENTETATE DIMEGLUMINE INJECTION, USP

GADOPENTETATE DIMEGLUMINE INJECTION, USP

Discontinued
DIN Number

02431513

Drug Class

Human

Market Date

N/A

Company
HC

Jubilant Draximage Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02431513
AIG Number0123846001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA01 GADOPENTETIC ACID
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

GADOPENTETATE DIMEGLUMINEActive
Strength: 469 MG / ML
Monograph: GADOPENTETATE DIMEGLUMINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.